CURRENT GOOD MANUFACTURING GUIDELINES FOR MEDICINAL PRODUCT

  • Shukla A
  • Vishnoi G
  • Das D
N/ACitations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

The holder of a manufacturing  authorisation must manufacture medicinal products so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Authorisation and do not place patients at risk due to inadequate safety, quality or efficacy. The attainment of this quality objective is the responsibility of senior management and requires the participation and commitment by staff in many different departments and at all levels within the company, by the company’s suppliers and by the distributors. To achieve the quality objective reliably there must be a comprehensively designed and correctly implemented system of Quality Assurance Incorporating Good Manufacturing Practice, and thus Quality Control and Quality Risk Management. It should be fully documented and its effectiveness monitored. All parts of the Quality Assurance systems should be adequately resourced with competent personnel, and suitable and sufficient premises, equipment and facilities. There are additional legal responsibilities for the holder of the manufacturing  authorisation and for the  authorised person Keywords: Good Manufacturing Practice, Quality control, Quality assurance, authorised

Cite

CITATION STYLE

APA

Shukla, A., Vishnoi, G., & Das, D. R. (2016). CURRENT GOOD MANUFACTURING GUIDELINES FOR MEDICINAL PRODUCT. Journal of Drug Delivery and Therapeutics, 6(2). https://doi.org/10.22270/jddt.v6i2.1201

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free